Citation Impact
Citing Papers
rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data
2014 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Novel therapeutic strategies targeting HIV integrase
2012
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development
2018
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data
2013
Passive immunotherapy of viral infections: 'super-antibodies' enter the fray
2018
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1
2023 StandoutNobel
Evolution of an HIV glycan–dependent broadly neutralizing antibody epitope through immune escape
2012
The yin and yang of viruses and interferons
2012
Tripartite-motif proteins and innate immune regulation
2010
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
High Prevalence and Incidence of Asymptomatic Sexually Transmitted Infections During Pregnancy and Postdelivery in KwaZulu Natal, South Africa
2014
Neutrophils at work
2014 Standout
Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults
2017
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Long-Term Balancing Selection in LAD1 Maintains a Missense Trans-Species Polymorphism in Humans, Chimpanzees, and Bonobos
2015 StandoutNobel
TRIM25 Enhances the Antiviral Action of Zinc-Finger Antiviral Protein (ZAP)
2017 StandoutNobel
Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey
2019
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
2012
Type I interferons in infectious disease
2015 Standout
COVID-19: A promising cure for the global panic
2020 Standout
Antiviral resistance of stem cells
2018 StandoutNobel
Discovery of O-Linked Carbohydrate on HIV-1 Envelope and Its Role in Shielding against One Category of Broadly Neutralizing Antibodies
2020
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes
2015 StandoutNobel
Neutrophil extracellular traps in immunity and disease
2017 Standout
Periodontitis: from microbial immune subversion to systemic inflammation
2014 Standout
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
2022
A Blueprint for HIV Vaccine Discovery
2012
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention
2012
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections
2020 Standout
SARS-CoV-2 variants, spike mutations and immune escape
2021 Standout
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
2018
Antimicrobial resistance: a global multifaceted phenomenon
2015 Standout
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
2015
Hidradenitis suppurativa
2020 Standout
Management of difficult multidrug‐resistant tuberculosis and extensively drug‐resistant tuberculosis: Update 2012
2012
Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells
2020 StandoutNobel
IL-36γ Augments Host Defense and Immune Responses in Human Female Reproductive Tract Epithelial Cells
2016
The Association Between a Darc Gene Polymorphism and Clinical Outcomes in African American Patients With Acute Lung Injury
2011
Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
2020 Nobel
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Long-term balancing selection maintains trans-specific polymorphisms in the human TRIM5 gene
2010
The acute respiratory distress syndrome
2012 Standout
Neutrophil Extracellular Traps Mediate a Host Defense Response to Human Immunodeficiency Virus-1
2012
Cross-Sectional Study of Genital, Rectal, and Pharyngeal Chlamydia and Gonorrhea in Women in Rural South Africa
2014
Estimating the burden of antimicrobial resistance: a systematic literature review
2018
Neutrophil recruitment and function in health and inflammation
2013 Standout
IFN-λ inhibits HIV-1 integration and post-transcriptional events in vitro, but there is only limited in vivo repression of viral production
2012
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis
2018
Pharmacokinetic Data Are Predictive of In Vivo Efficacy for Cefixime and Ceftriaxone against Susceptible and Resistant Neisseria gonorrhoeae Strains in the Gonorrhea Mouse Model
2019
Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
2015 StandoutNobel
Sexually Transmitted Infections Treatment Guidelines, 2021
2021 Standout
Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies
2016
Hepatitis C virus infects rhesus macaque hepatocytes and simianized mice
2015 StandoutNobel
Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV
2014
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments
2013
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems
2014 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance
2016 StandoutNobel
Antibodies in HIV-1 Vaccine Development and Therapy
2013 Science
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Polyreactivity and Autoreactivity among HIV-1 Antibodies
2014
Neutralizing antibodies to HIV-1 induced by immunization
2013
TRIM22: A Diverse and Dynamic Antiviral Protein
2012
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
2011 Science
Control of foreign Ag‐specific Ab responses by Treg and Tfr
2020 StandoutNobel
Mucosal Immunity in the Female Genital Tract, HIV/AIDS
2014
Interleukin-10 and Immunity against Prokaryotic and Eukaryotic Intracellular Pathogens
2011
Broadly Neutralizing Antiviral Antibodies
2013
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
2011
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
2012
Daily Oral Tenofovir and Emtricitabine–Tenofovir Preexposure Prophylaxis Reduces Herpes Simplex Virus Type 2 Acquisition Among Heterosexual HIV-1–Uninfected Men and Women
2014
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men
2012
Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles
2023
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
2020
Non‐randomized studies as a source of complementary, sequential or replacement evidence for randomized controlled trials in systematic reviews on the effects of interventions
2013
Herpes Simplex Virus Type 2 Acquisition Among HIV-1–Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study
2017
Cross-Reactivity to Kynureninase Tolerizes B Cells That Express the HIV-1 Broadly Neutralizing Antibody 2F5
2019
Progress toward active or passive HIV-1 vaccination
2016
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Interferon regulatory factor 2 protects mice from lethal viral neuroinvasion
2016 StandoutNobel
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
2019 Standout
Topical microbicides and HIV prevention in the female genital tract
2014
Works of Lise Werner being referenced
Innate Antibacterial Activity in Female Genital Tract Secretions Is Associated with Increased Risk of HIV Acquisition
2015
Treatment Outcomes for Extensively Drug-Resistant Tuberculosis and HIV Co-infection
2013
Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression
2011
Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel
2016
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
2011
High Burden of Human Papillomavirus (HPV) Infection among Young Women in KwaZulu-Natal, South Africa
2016
Duffy-Null–Associated Low Neutrophil Counts Influence HIV-1 Susceptibility in High-Risk South African Black Women
2011
Tenofovir Gel for the Prevention of Herpes Simplex Virus Type 2 Infection
2015
Human TRIM5α Expression Levels and Reduced Susceptibility to HIV‐1 Infection
2009
Interleukin‐10 Promoter Polymorphisms Influence HIV‐1 Susceptibility and Primary HIV‐1 Pathogenesis
2009
Symptomatic Vaginal Discharge Is a Poor Predictor of Sexually Transmitted Infections and Genital Tract Inflammation in High-Risk Women in South Africa
2012
Association of TRIM22 with the Type 1 Interferon Response and Viral Control during Primary HIV-1 Infection
2010
Primary Capreomycin Resistance Is Common and Associated With Early Mortality in Patients With Extensively Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa
2015
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4 + T Cell Decline and High Viral Load during Acute Infection
2011
High Incidence of Hospital Admissions With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Among South African Health Care Workers
2010